Please assess the completion status of the following clinical trial:

Trial Title: Inflammation and Insulin Resistance in Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets the American College of Rheumatology (ACR) criteria for the diagnosis of rheumatoid arthritis (RA)~* Stable disease activity, as evidenced by no change in immunomodulating or anti-inflammatory therapy in the 1 month before study entry~* Moderate disease activity, as reflected by a minimum of three swollen and tender joints~* If female of childbearing potential, willing to use effective method of contraception~Exclusion Criteria:~* Allergic to pioglitazone~* Active cancer (other than skin cancer)~* HIV infected~* Currently receiving dialysis~* Received an organ or bone marrow transplant~* Heart failure~* Severe edema, as judged by the principal investigator~* Diabetes mellitus requiring drug therapy: levels of aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than twice the upper limit of normal~* Underwent major surgery in the 3 months before study entry~* Severe comorbid condition that is likely to compromise survival or study participation~* Currently receiving gemfibrozil or rifampin~* Osteoporosis and not receiving osteoporosis medications~* Unwillingness, or other inability, to cooperate with study procedures~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo First (Type: EXPERIMENTAL): Placebo for first 8 weeks, then washout period for 4 weeks, and finally pioglitazone for 8 weeks.
- Pioglitazone First (Type: EXPERIMENTAL): Pioglitazone for first 8 weeks, then washout period for 4 weeks, and finally placebo for 8 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).